-
N-(trans-4-(2-Methoxyethoxy)cyclohexyl)-6-(thiazol-5-yl)-1H-pyrrolo[2,3-b]pyridine-4-carboxamide
-
BD015803042641484-61-798%
-
¥1700.050mg
-
4-((trans-4-(2-Methoxyethoxy)cyclohexyl)amino)-1-methyl-6-(thiazol-5-yl)quinolin-2(1H)-one
-
BD011316501700637-55-398%
-
¥1098.025mg
-
2-(1H-imidazol-1-yl)-N-(trans-4-(2-methoxyethoxy)cyclohexyl)-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide
-
BD015141662597933-17-898%
-
¥905.025mg
-
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chromenylium chloride
-
BD1356197084-24-498%
-
¥2295.050mg
-
CD38 inhibitor 3
-
BD023866752857868-82-598%
-
¥
-
Ara-F-NAD+
-
BD01432511133575-27-698%
-
¥
-
Luteolinidinchloride
-
BD1368691154-78-599+%
-
¥10430.05mg
-
Isatuximab
-
BD014814371461640-62-998%
-
¥
-
CD38 inhibitor 2
-
BD015205482597933-78-198%
-
¥
-
Ara-F-NAD+ sodium
-
BD0230315398%
-
¥
-
Mezagitamab
-
BD018610742227490-52-895%
-
¥